Clinical Study

Evaluation of the Macular, Peripapillary Nerve Fiber Layer and Choroid Thickness Changes in Behçet’s Disease with Spectral-Domain OCT

Table 3

Volumes of macula in patients with BD and control.

VariablesGroupsOcular Involvement
Control ( )Behcet ( ) Present ( )Absent ( )

CSF0.21 ± 0.020.21 ± 0.020.3760.21 ± 0.020.21 ± 0.020.987
SIM0.55 ± 0.030.54 ± 0.030.0030.53 ± 0.030.54 ± 0.030.142
TIM0.54 ± 0.020.52 ± 0.030.0040.52 ± 0.020.51 ± 0.030.746
IIM0.54 ± 0.030.53 ± 0.030.0130.53 ± 0.030.53 ± 0.040.831
NIM0.54 ± 0.030.52 ± 0.030.0070.53 ± 0.030.54 ± 0.030.443
SOM1.6 ± 0.091.56 ± 0.090.0051.52 ± 0.11.58 ± 0.080.018
TOM1.61 ± 0.111.58 ± 0.120.0711.48 ± 0.091.52 ± 0.080.133
IOM1.56 ± 0.081.53 ± 0.10.0531.54 ± 0.161.54 ± 0.080.859
NOM1.61 ± 0.121.58 ± 0.120.1181.62 ± 0.11.67 ± 0.080.019
AVE0.97 ± 0.040.95 ± 0.050.0040.94 ± 0.050.96 ± 0.040.171

Values are expressed as mean ± SD; : number of case; CSF: central subfield; SIM: superior inner macula; TIM: temporal inner macula; IIM: inferior inner macula; NIM: nasal inner macula; SOM: superior outer macula; TOM: temporal outer macula; IOM: inferior outer macula; NOM: nasal outer macula; AVE: average volume.